110 related articles for article (PubMed ID: 12439697)
1. Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recovery.
Ali MY; Oyama Y; Monreal J; Winter J; Tallman M; Gordon LI; Williams S; Singhal S; Mehta J
Bone Marrow Transplant; 2002 Dec; 30(11):749-52. PubMed ID: 12439697
[TBL] [Abstract][Full Text] [Related]
2. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
[TBL] [Abstract][Full Text] [Related]
3. How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?
Verma A; Pedicano J; Trifilio S; Singhal S; Tallman M; Winter J; Williams S; Gordon L; Monreal J; Mehta J
Bone Marrow Transplant; 2004 Apr; 33(7):715-9. PubMed ID: 14743195
[TBL] [Abstract][Full Text] [Related]
4. Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantation.
Rihn C; Cilley J; Naik P; Pedicano AV; Mehta J
Haematologica; 2004 Jun; 89(6):763-4. PubMed ID: 15194552
[TBL] [Abstract][Full Text] [Related]
5. Low-dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses.
Suh C; Kim HJ; Kim SH; Kim S; Lee SJ; Lee YS; Kim EK; Kim SB; Lee JS; Kim MW; Kim K; Yoon SS
Transfusion; 2004 Apr; 44(4):533-8. PubMed ID: 15043569
[TBL] [Abstract][Full Text] [Related]
6. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte transfusions revisited: stem cell graft stimulation in graft failure.
Taskinen M; Talvensaari K; Hovi L; Vettenranta K; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2008 Jun; 50(6):1247-52. PubMed ID: 18293387
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.
Babatunde AS; Tan DC; Heng KK; Lee JJ; Loh YS; Hwang WY; Koh MB; Goh YT; Linn YC
Bone Marrow Transplant; 2009 Aug; 44(3):175-83. PubMed ID: 19204715
[TBL] [Abstract][Full Text] [Related]
9. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
10. Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster engraftment without increased resource utilization.
Thompson JM; Carlton P; Akard LP; Dugan MJ; Jansen J
Transfusion; 2009 Mar; 49(3):548-54. PubMed ID: 19040494
[TBL] [Abstract][Full Text] [Related]
11. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
12. Criteria for marrow engraftment: comparison of reticulocyte maturity index with conventional parameters.
Dalal BI; Stockford GR; Naiman SC; Spinelli JJ; Phillips GL
Bone Marrow Transplant; 1996 Jan; 17(1):91-2. PubMed ID: 8673062
[TBL] [Abstract][Full Text] [Related]
13. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
14. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
Ergene U; Cağirgan S; Pehlivan M; Yilmaz M; Tombuloğlu M
Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
[TBL] [Abstract][Full Text] [Related]
16. Reticulocyte maturation parameters are reliable early predictors of hematopoietic engraftment after allogeneic stem cell transplantation.
Molina JR; Sanchez-Garcia J; Torres A; Alvarez MA; Serrano J; Casaño J; Gomez P; Martinez F; Rodriguez A; Martin C
Biol Blood Marrow Transplant; 2007 Feb; 13(2):172-82. PubMed ID: 17241923
[TBL] [Abstract][Full Text] [Related]
17. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT.
Klumpp TR; Herman JH; Schnell MK; Goldberg SL; Mangan KF
Bone Marrow Transplant; 1996 Sep; 18(3):559-64. PubMed ID: 8879617
[TBL] [Abstract][Full Text] [Related]
18. Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment.
Cairo MS; Gillan ER; Weinthal J; Yancik S; van de Ven C; Ho W; Shen V; Buzby JS; Suen Y
Bone Marrow Transplant; 1993 Feb; 11(2):155-61. PubMed ID: 7679598
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation].
Tian H; Zhou SY
Ai Zheng; 2002 Aug; 21(8):896-9. PubMed ID: 12478902
[TBL] [Abstract][Full Text] [Related]
20. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
